News Detail

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga · 05/13 12:10

Listen to the news

Gainers

CNS Pharma (NASDAQ:CNSP) shares rose 90.1% to $2.3 during Tuesday's pre-market session. The market value of their outstanding shares is at $6.7 million.
GlucoTrack (NASDAQ:GCTK) shares increased by 25.15% to $0.19. The market value of their outstanding shares is at $4.7 million.
Xilio Therapeutics (NASDAQ:XLO) shares moved upwards by 23.11% to $0.9. The market value of their outstanding shares is at $46.5 million. The company's, Q1 earnings came out 3 days ago.
Arcturus Therapeutics (NASDAQ:ARCT) shares moved upwards by 21.22% to $14.05. The company's market cap stands at $381.0 million. As per the news, the Q1 earnings report came out yesterday.
Silence Therapeutics (NASDAQ:SLN) shares moved upwards by 11.22% to $4.26. The market value of their outstanding shares is at $201.1 million. As per the news, the Q1 earnings report came out 3 days ago.
Redhill Biopharma (NASDAQ:RDHL) stock rose 10.49% to $2.21. The market value of their outstanding shares is at $3.9 million.

Losers

Polyrizon (NASDAQ:PLRZ) stock declined by 91.8% to $0.03 during Tuesday's pre-market session.
Sangamo Therapeutics (NASDAQ:SGMO) stock decreased by 36.8% to $0.47. The market value of their outstanding shares is at $106.0 million. As per the news, the Q1 earnings report came out yesterday.
Accelerate Diagnostics (NASDAQ:AXDX) stock fell 21.63% to $0.11. The company's market cap stands at $2.6 million.
Klotho Neurosciences (NASDAQ:KLTO) shares declined by 19.73% to $0.14. The market value of their outstanding shares is at $3.9 million.
Coherus BioSciences (NASDAQ:CHRS) stock fell 16.67% to $0.85. The market value of their outstanding shares is at $98.5 million. As per the news, the Q1 earnings report came out yesterday.
Entero Therapeutics (NASDAQ:ENTO) shares decreased by 16.59% to $0.35. The market value of their outstanding shares is at $1.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.

What's Trending

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.